Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

<< Previous

Bullboard Posts

Next >>

Post by floatinketuckyon Feb 10, 2022 4:47am

507 Views

Post# 34415405

$TLTFF THE STONGEST CHOICE FOR NMIBC NONRESPONSE.

67 %CR AT 18 months from one treatment. Patients then were released from the study and only the doctor and the patient knew the 24 month results.

Then the Principal Investigator for the PH2 PIVITOL study starded the first dozen patients at about 70 pecent dose. Its almost like he was concerned for OVERTREATING PATIENTS. But then the principal investigator say ITS ALRIGHT FULL DOSES FOR ALL NEW PATIENTS.

That little TLTFF FDA DARLING IS READY TO GE OUT TONIGHT!

What do ya think about that boys?!?!?!?!?!